Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials
Mahner, S, Eulenburg, C, Staehle, A, Wegscheider, K, Reuss, A, Pujade-Lauraine, E, Harter, P, Ray-Coquard, I, Pfisterer, J, du Bois, A
Published in European journal of cancer (1990) (01.01.2013)
Published in European journal of cancer (1990) (01.01.2013)
Get full text
Journal Article
Non-enrolment of ovarian cancer patients in clinical trials: reasons and background
Harter, P., du Bois, A., Schade-Brittinger, C., Burges, A., Wollschlaeger, K., Gropp, M., Schmalfeldt, B., Huober, J., Staehle, A., Pfisterer, J.
Published in Annals of oncology (01.11.2005)
Published in Annals of oncology (01.11.2005)
Get full text
Journal Article
Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)
du Bois, A., Burges, A., Meier, W., Pfisterer, J., Schmalfeldt, B., Richter, B., Jackisch, C., Staehle, A., Kimmig, R., Elser, G.
Published in Annals of oncology (01.01.2006)
Published in Annals of oncology (01.01.2006)
Get full text
Journal Article
A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC–IV (AGO-OVAR protocol OVAR-8)
du Bois, A., Belau, A., Wagner, U., Pfisterer, J., Schmalfeldt, B., Richter, B., Staehle, A., Jackisch, C., Lueck, H.J., Schroeder, W., Burges, A., Olbricht, S., Elser, G.
Published in Gynecologic oncology (01.02.2005)
Published in Gynecologic oncology (01.02.2005)
Get full text
Journal Article
378 Phase II study of AEZS-108 (AN-152), a targeted cytotoxic LHRH analog, in patients with LHRH receptor positive endometrial cancer. Protocol AGO-GYN 5, AGO Study Group, Germany
Emons, G, Sehouli, J, Gorchev, G, Hristamian, A, Staehle, A, Hanker, L.C, Wimberger, P, Beckmann, M.W, Taskova, V, Gruendker, C
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
AB0159 INTERLEUKIN-16 PLAYS A ROLE IN THE PATHOGENESIS OF SYSTEMIC SCLEROSIS
Luo, J., Kerstein-Staehle, A., Comduehr, S., Dreyer, T., Müller, A., Schinke, S., Riemekasten, G.
Published in Annals of the rheumatic diseases (01.06.2020)
Published in Annals of the rheumatic diseases (01.06.2020)
Get full text
Journal Article
FRI0001 NEUTROPHILS IN GRANULOMATOSIS WITH POLYANGIITIS DISPLAY FEATURES OF PYROPTOSIS
Kerstein-Staehle, A., Leinung, N., Meyer, J., Pitann, S., Müller, A., Riemekasten, G., Lamprecht, P.
Published in Annals of the rheumatic diseases (01.06.2020)
Published in Annals of the rheumatic diseases (01.06.2020)
Get full text
Journal Article
POS0829 SPECTRUM OF ANCA-SPECIFICITIES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS IN A RETROSPECTIVE MULTICENTER STUDY
Arnold, S., Mahrhold, J., Kerstein-Staehle, A., Csernok, E., Hellmich, B., Venhoff, N., Thiel, J., Affeldt, K., Jahnke, A., Riemekasten, G., Lamprecht, P.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
00014 A PHASE II STUDY OF THE AGO OVARIAN CANCER STUDY GROUP (AGO-OVAR 2.6): ZD1839 IN COMBINATION WITH TAMOXIFEN IN REFRACTORY OVARIAN CANCER
Sehouli, J., Wagner, U., du Bois, A., Pfisterer, J., Houber, J., Loibl, S., Lueck, H. J., Gropp, M., Staehle, A., Schmalfeldt, B., Meier, W., Jackisch, C.
Published in International journal of gynecological cancer (01.09.2005)
Published in International journal of gynecological cancer (01.09.2005)
Get full text
Journal Article
AB0496 AUTOANTIBODIES TARGETING COMPLEMENT RECEPTORS 3A AND 5A1 ARE DECREASED IN ANCA-ASSOCIATED VASCULITIS AND CORRELATE WITH HIGHER RELAPSE RATE
Klapa, S., Müller, A., Koch, A., Kerstein-Staehle, A., Kaehler, W., Heidecke, H., Schinke, S., Huber-Lang, M., Nitschke, M., Pitann, S., Karsten, C., Riemekasten, G., Lamprecht, P.
Published in Annals of the rheumatic diseases (01.06.2020)
Published in Annals of the rheumatic diseases (01.06.2020)
Get full text
Journal Article
Paclitaxel‐carboplatin‐gemcitabine (TCG) as first‐line treatment of ovarian cancer: a prospective multicenter phase II study (AGO‐OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO‐OVAR 9, GINECO‐TCG, NSGO‐OC‐0102) comparing TCG with standard TC
BOIS, A., SEHOULI, J., LUND, B., JOLY, F., HUOBER, J., JENSEN, T.S., LEVY, E., HEILMANN, V., BOMAN, K., HARDY‐BESSARD, A.C., BURGES, A., MÄENPÄÄ, J., PUJADE‐LAURAINE, E., PFISTERER, J., GROPP, M., STAEHLE, A., WIMBERGER, P., JACKISCH, C., SCHMALFELDT, B., BELAU, A., LOIBL, S., WOLLSCHLAEGER, K., CANZLER, U., ROCHON, J.
Published in International journal of gynecological cancer (01.11.2005)
Published in International journal of gynecological cancer (01.11.2005)
Get full text
Journal Article
000103 PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102)
du Bois, A., Schroeder, W., Jelic, S., Weber, B., Sehouli, J., Keern, J., Priou, F., Huober, J., Railing, M., Ray-Coquard, I., Heilmann, V., Surges, A., Pfisterer, J., Gropp, M., Staehle, A., Wimberger, P., Jackisch, C., Mueller, H. H.
Published in International journal of gynecological cancer (01.09.2005)
Published in International journal of gynecological cancer (01.09.2005)
Get full text
Journal Article
Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) comparing TCG with standard TC
DU BOIS, A., SEHOULI, J., LUND, B., JOLY, F., HUOBER, J., JENSEN, T. S., LEVY, E., HEILMANN, V., BOMAN, K., HARDY-BESSARD, A. C., BURGES, A., MÄENPÄÄ, J., PUJADE-LAURAINE, E., PFISTERER, J., GROPP, M., STAEHLE, A., WIMBERGER, P., JACKISCH, C., SCHMALFELDT, B., BELAU, A., LOIBL, S., WOLLSCHLAEGER, K., CANZLER, U., ROCHON, J.
Published in International journal of gynecological cancer (01.11.2005)
Published in International journal of gynecological cancer (01.11.2005)
Get full text
Journal Article
Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study
Arnold, Sabrina, Mahrhold, Juliane, Kerstein-Staehle, Anja, Riemekasten, Gabriela, Csernok, Elena, Hellmich, Bernhard, Venhoff, Nils, Thiel, Jens, Affeldt, Kai, Jahnke, Annika, Lamprecht, Peter
Published in Clinical and experimental rheumatology (01.04.2023)
Published in Clinical and experimental rheumatology (01.04.2023)
Get more information
Journal Article
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
DU BOIS, Andreas, HERRSTEDT, Jorn, KURZEDER, Christian, JELIC, Svetislav, PUJADE-LAURAINE, Eric, BURGES, Alexander, PFISTERER, Jacobus, GROPP, Martina, STAEHLE, Anne, WIMBERGER, Pauline, JACKISCH, Christian, SEHOULI, Jalid, HARDY-BESSARD, Anne-Claire, MÜLLER, Hans-Helge, HARTER, Philipp, KRISTENSEN, Gunnar, JOLY, Florence, HUOBER, Jens, AVALL-LUNDQVIST, Elisabeth, WEBER, Béatrice
Published in Journal of clinical oncology (20.09.2010)
Published in Journal of clinical oncology (20.09.2010)
Get full text
Journal Article
Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: A prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut)
du Bois, A, Pfisterer, J, Burchardi, N, Loibl, S, Huober, J, Wimberger, P, Burges, A, Stähle, A, Jackisch, C, Kölbl, H
Published in Gynecologic oncology (01.12.2007)
Published in Gynecologic oncology (01.12.2007)
Get full text
Journal Article
Pegylated liposomal doxorubicin and carboplatin in malignant mixed epithelial mesenchymal and mesenchymal gynecologic tumors: A phase II trial of the AGO study group
Harter, P., Canzler, U., Lueck, H., Reuss, A., Meier, W., Fehm, T. N., Staehle, A., Burges, A., Kurzeder, C., Sehouli, J., Baumann, K. H., Hanker, L. C., Wimberger, P., Schroeder, W., Gropp, M., Mahner, S., Du Bois, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase II study of AEZS-108 (AN-152), a targeted cytotoxic LHRH analog, in patients with LHRH receptor-positive platinum resistant ovarian cancer
Emons, G., Tomov, S., Harter, P., Sehouli, J., Wimberger, P., Staehle, A., Hanker, L. C., Hilpert, F., Dall, P., Gruendker, C.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article